These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1053 related articles for article (PubMed ID: 15767107)
1. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107 [TBL] [Abstract][Full Text] [Related]
2. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method. Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109 [TBL] [Abstract][Full Text] [Related]
3. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI. Hakyemez B; Erdogan C; Gokalp G; Dusak A; Parlak M Clin Radiol; 2010 Jan; 65(1):15-20. PubMed ID: 20103416 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. Hakyemez B; Erdogan C; Bolca N; Yildirim N; Gokalp G; Parlak M J Magn Reson Imaging; 2006 Oct; 24(4):817-24. PubMed ID: 16958061 [TBL] [Abstract][Full Text] [Related]
5. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Shin JH; Lee HK; Kwun BD; Kim JS; Kang W; Choi CG; Suh DC AJR Am J Roentgenol; 2002 Sep; 179(3):783-9. PubMed ID: 12185064 [TBL] [Abstract][Full Text] [Related]
6. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. Young R; Babb J; Law M; Pollack E; Johnson G J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374 [TBL] [Abstract][Full Text] [Related]
7. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results. Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832 [TBL] [Abstract][Full Text] [Related]
8. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas. Thomsen H; Steffensen E; Larsson EM Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021 [TBL] [Abstract][Full Text] [Related]
9. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Sugahara T; Korogi Y; Kochi M; Ikushima I; Hirai T; Okuda T; Shigematsu Y; Liang L; Ge Y; Ushio Y; Takahashi M AJR Am J Roentgenol; 1998 Dec; 171(6):1479-86. PubMed ID: 9843274 [TBL] [Abstract][Full Text] [Related]
10. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950 [TBL] [Abstract][Full Text] [Related]
11. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Fayed N; Dávila J; Medrano J; Olmos S Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889 [TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374 [TBL] [Abstract][Full Text] [Related]
15. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma. Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of perfusion MRI in differentiating low-grade and high-grade gliomas: advanced MRI in glioma, A Siriraj project. Direksunthorn T; Chawalparit O; Sangruchi T; Witthiwej T; Tritrakarn SO; Piyapittayanan S; Charnchaowanish P; Pornpunyawut P; Sathornsumetee S J Med Assoc Thai; 2013 Sep; 96(9):1183-90. PubMed ID: 24163995 [TBL] [Abstract][Full Text] [Related]
17. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema. Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234 [TBL] [Abstract][Full Text] [Related]
18. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889 [TBL] [Abstract][Full Text] [Related]
19. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Yang D; Korogi Y; Sugahara T; Kitajima M; Shigematsu Y; Liang L; Ushio Y; Takahashi M Neuroradiology; 2002 Aug; 44(8):656-66. PubMed ID: 12185543 [TBL] [Abstract][Full Text] [Related]
20. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging. Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]